Letters, Testimony & Comments
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
On behalf of the 23 undersigned industrial, environmental, food and agricultural biotechnology companies, we write to express our...
June 12 2012
If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California...
February 17 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
Priority...
February 14 2012
February 25, 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010
Submission to the Senate Legal and Constitutional Affairs Legislation...
February 25 2011
February 4, 2010
February 4 2010
October 8, 2009
Recommendations in the Secretary’s Advisory Committee on Genetics, Health and Society draft report on Gene Patenting and Licensing...
October 8 2009
October 8, 2009
October 8 2009
September 9, 2009
Dear Secretary Vilsack:
We are writing today to bring to your attention a court case that has the potential to negatively impact the...
September 9 2009
May 15, 2009
May 15 2009
May 15, 2009
May 15 2009
March 19, 2009
March 19 2009
October 30, 2007
The Comments of the
Biotechnology Industry Organization
on the United States Patent & Trademark Office
Proposed Rule Changes...
October 30 2007
March 21, 2002
March 21 2002
September 26, 2001
The Honorable Michael Harris, M.P.P.
Premier of Ontario
Legislative Assembly of Ontario
Room 281
Legislative Building
Toronto,...
September 26 2001
July 13, 2000
WASHINGTON, D.C. (July 13, 2000) -- Executives from two Biotechnology Industry Organization (BIO) member companies testified today...
July 13 2000
Letters, Testimony & Comments
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological advances and the innovation that spurs it are the primary drivers of economic growth in the modern era, it is critical that patent laws and practices properly motivate and reward innovation.
June 12 2012
February 17 2012
February 14 2012
February 25 2011
BIO believes that the proposed amendment would, if adopted, have significant unintended and adverse consequences in all sectors of biotechnology and for patients and consumers in Australia. This amendment also would fail to affect its intended purpose, which is to advance medical and scientific research and the diagnosis and cure of human illness and disease.
Want to learn more about the biotech industry?
Business Solutions Sponsor
